About IntelliHep
IntelliHep is a company based in Liverpool (United Kingdom) founded in 2004.. The company has 3 employees as of May 31, 2020. IntelliHep offers products and services including Heparin-based Chemical Entities. IntelliHep operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Denali Therapeutics, C4 Therapeutics and Erasca, among others.
- Headquarter Liverpool, United Kingdom
- Employees 3 as on 31 May, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Intellihep Ltd
- Date of Incorporation 13 May, 2002
- Jurisdiction LIVERPOOL, MERSEYSIDE
-
Annual Revenue
$18.47 K (USD)-54as on May 31, 2023
-
Net Profit
$4.24 K (USD)0as on May 31, 2023
-
EBITDA
-
Latest Funding Round
$119.2 K (USD), Grant
Oct 01, 2020
- Investors
-
Employee Count
3
as on May 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntelliHep
IntelliHep offers a comprehensive portfolio of products and services, including Heparin-based Chemical Entities. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Novel compounds for treating neurodegeneration and cancer diseases
Funding Insights of IntelliHep
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $119,198
-
First Round
First Round
(01 Oct 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Grant - IntelliHep | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IntelliHep
IntelliHep has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IntelliHep
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IntelliHep
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intellihep Comparisons
Competitors of IntelliHep
IntelliHep operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Denali Therapeutics, C4 Therapeutics and Erasca, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about IntelliHep
When was IntelliHep founded?
IntelliHep was founded in 2004 and raised its 1st funding round 16 years after it was founded.
Where is IntelliHep located?
IntelliHep is headquartered in Liverpool, United Kingdom.
How many employees does IntelliHep have?
As of May 31, 2020, the latest employee count at IntelliHep is 3.
What is the annual revenue of IntelliHep?
Annual revenue of IntelliHep is $18.47K as on May 31, 2023.
What does IntelliHep do?
IntelliHep was established in 2004 in Liverpool, United Kingdom, within the biotechnology sector. Heparin-based therapeutics are developed for treating neurodegeneration and cancer. A platform technology is utilized to generate diverse libraries of heparin glycans targeted at specific conditions, including Alzheimers disease. Operations focus on advancing these treatments through research and development processes.
Who are the top competitors of IntelliHep?
IntelliHep's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does IntelliHep offer?
IntelliHep offers Heparin-based Chemical Entities.
Who are IntelliHep's investors?
IntelliHep has 1 investor. Key investors include European Union.